Právní předpis byl sestaven k datu 12.05.2009.
Zobrazené znění právního předpisu je účinné od 13.05.2009 do 12.05.2009.
114
VYHLÁŠKA
xx xxx 17. xxxxx 2009,
xxxxxx xx xxxx xxxxxxxx x. 384/2007 Sb., x xxxxxxx referenčních xxxxxx
Ministerstvo xxxxxxxxxxxxx xxxxxxx podle §39c odst. 1 xxxxxx x. 48/1997 Xx., x veřejném xxxxxxxxxx pojištění x x xxxxx x xxxxxxxx některých souvisejících xxxxxx, xx xxxxx xxxxxx x. 261/2007 Xx.:
Xx. I
Xxxxxxx x vyhlášce č. 384/2007 Sb., x xxxxxxx xxxxxxxxxxxx skupin, xxx:
"Xxxxxxx x vyhlášce x. 384/2007 Xx.
Xxxxxx xxxxxxxxxxxx xxxxxx
xxxxx xxxx- xxxxxxxx xxxxxxx | xxxxxxxxxxxx skupina | xxxxx referenční skupiny | xxxxxxxxxx xxxxxxx*) | xxxxxx xxxxx x xxxxxxxxxx xxxxxxx xxxxxxxxxxx |
1 | Xxxxxx x xxxxxxx xxxxxxxxxxxxxxxx vředové xxxxxxx x xxxxxxxx xxxxxxx xxxxx | 1/2 | léčiva x xxxxxxx gastroduodenální xxxxxxx xxxxxxx x xxxxxxxx choroby jícnu, xxxxxxxxxxx X2 xxxxxxxxx, xxxxxx. | X02XX01 xxxxxxxxx, X02XX02 xxxxxxxxx, A02BA03 xxxxxxxxx |
1/3 | léčiva x xxxxxxx xxxxxxxxxxxxxxxx xxxxxxx xxxxxxx a refluxní xxxxxxx jícnu, inhibitory xxxxxxxxx xxxxx, x.x. | X02XX01 xxxxxxxxx, X02XX02 xxxxxxxxxxx, X02XX03 xxxxxxxxxxx, X02XX05 xxxxxxxxxxx | ||
1/4 | léčiva x xxxxxxx xxxxxxxxxxxxxxxx xxxxxxx xxxxxxx x xxxxxxxx xxxxxxx xxxxx, xxxxxxxxxx xxxxxxxxx pumpy, xxxxxx. | X02XX01 omeprazol, X02XX02 xxxxxxxxxxx, A02BC05 xxxxxxxxxxx | ||
2 | Xxxxxxxxxxxx | 2/1 | xxxxxxxxxxxx, x.x. | X03XX04 xxxxxxxxx, X03XX06 xxxxxxxxx xxxxxx, A03AD02 xxxxxxxxxx, A03BB01 xxxxxxxxxxxxxxx |
2/2 | xxxxxxxxxxxx, xxxxxx. | A03AD01 xxxxxxxxx, X03XX02 xxxxxxxxxx | ||
3 | Xxxxxxxxxxx | 3/1 | xxxxxxxxxxx, p.o. | X03XX01 xxxxxxxxxxxxx, A03FA03 xxxxxxxxxx, X03XX xxxxxxx |
4 | Xxxxxxxxxxx | 4/1 | xxxxxxxxxxx, xxxxxxx, x.x. | A04AA01 xxxxxxxxxxx, X04XX02 xxxxxxxxxxx |
4/2 | xxxxxxxxxxx, xxxxxxx, xxxxxx. x xxxx. xxxxxxxx | X04XX01 ondansetron, X04XX02 xxxxxxxxxxx, X04XX05 xxxxxxxxxxxx | ||
4/3 | xxxxxxxxxxx, xxxxxxx, p.o | X06XX03 xxxxxxxxxxxxxxx, A04AD xxxxxxxx | ||
5 | Xxxxxx x xxxxxxx xxxxxxxxxxx xxxxxxxxx onemocnění | 5/1 | xxxxxx x terapii xxxxxxxxxxx xxxxxxxxx xxxxxxxxxx, xxxxxxxx arninosalicylová x xx xxxxx xxxxxxx, x.x. | X07XX01 xxxxxxxxxxxx, X07XX02 xxxxxxxxx |
6 | Xxxxxxxxxxxxx mikroorganismy | 6/1 | xxxxxxxxxxxxx xxxxxxxxxxxxxx, x.x. | X07XX protiprůjmové mikroorganismy - Xxxxxxxxxxx coli, X07XX01 organismy produkující xxxxxxxx xxxxxxx, X07XX02 Xxxxxxxxxxxxx xxxxxxxx sicatus |
7 | Xxxxxxxxxxxxx přípravky | 7/1 | xxxxxxxxxxxxx xxxxxxxxx, xxxxxxxxxxxxx lékové xxxxx, x.x. | X09XX02 xxxxxxxxxxxxx xxxxxxxxx - xxxxxxxxxxxxx xxxxxx formy xxx 20&xxxx;000 X v xxxxx tabletě |
8 | Xxxxxx x terapii xxxxxxx - xxxxxxxx | 8/1 | xxxxxx k xxxxxxx diabetu, xxxxxxx xxxxxx - lahvičky, xxxxx. | X10XX01 xxxxxxx xxxxxx xxxxxx působící, X10XX01 xxxxxxx lidský xxxxxxx dlouze působící |
8/2 | xxxxxx k terapii xxxxxxx, insulin lidský - cartridge, xxxxxxx xxxxxxxx - xxxxxxxx x xxxxxxxxx, parent. | X10XX01 xxxxxxx xxxxxx, X10XX04 xxxxxxx xxxxxx, X10XX05 insulin xxxxxx, X10XX06 insulin glulisin, X10XX01 insulin lidský, X10XX01 xxxxxxx xxxxxx, X10XX04 xxxxxxx xxxxxx, X10XX05 insulin xxxxxx, | ||
8/3 | xxxxxx k terapii xxxxxxx, xxxxxxxx x xxxxxxx dlouze působící, xxxxxx. | X10XX04 insulin xxxxxxx, X10XX05 xxxxxxx xxxxxxx | ||
9 | Xxxxxx x xxxxxxx diabetu | 9/1 | xxxxxx x xxxxxxx xxxxxxx, deriváty xxxxxxxxxxxx - X. x II. generace, x.x. (xxxxx xxxxxxxxx, xxxxxxxxxx x xxxxxxxxxxx) | X10XX01 xxxxxxxxxxxx, A10BB03 xxxxxxxxxx, |
9/2 | xxxxxx k xxxxxxx xxxxxxx, xxxxxxxx xxxxxxxxxxxx - X. xxxxxxxx, p.o. | A10BB07 xxxxxxxx, X10XX09 gliklazid, X10XX12 xxxxxxxxxx | ||
9/3 | xxxxxx x terapii xxxxxxx, xxxxxxxxx, p.o. | X10XX02 xxxxxxxxxxxx, X10XX03 xxxxxxxxxxx | ||
9/4 | xxxxxx k terapii xxxxxxx, glinidy, p.o. | X10XX02 repaglinid, X10XX03 xxxxxxxxxx | ||
9/5 | xxxxxx x xxxxxxx xxxxxxx, léčiva xxxxxxxxxxx xxxxxxxxxxx systém | X10XX01 xxxxxxxxxxx, X10XX02 xxxxxxxxxxxx, X10XX04 xxxxxxxx, X10XX07 liraglutid | ||
10 | Xxxxxx x xxxxxxx xxxxxxxx minerálů | 10/1 | xxxxxx x terapii xxxxxxxx xxxxxxxx, xxxx xxxxxxx, x.x. | A12AA04 xxxxxxxxx xxxxxxxx, X12XX07 xxxxxxx xxxxxxxx |
10/2 | xxxxxx x xxxxxxx xxxxxxxx xxxxxxxx, xxxx xxxxxxx, x.x. | A12CC06 xxxxxxx xxxxxxxxx, X12XX09 xxxxxx xxxxxxxxx | ||
11 | Xxxxxx x xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxxxxxxxx poruch xxxxxxxxxx xxxxxxxxxxx | 11/1 | xxxxxx x dlouhodobé xxxxxxxxxxx terapii dědičných xxxxxx xxxxxxxxxx xxxxxxxxxxx, xxxxxx. | X16XX03 xxxxxxxxxx xxxx, X16XX04 xxxxxxxxxx xxxx |
12 | Léčiva x xxxxxxx xxxx x profylaxi tromboembolických xxxxxxxxxx | 12/1 | xxxxxx x xxxxxxx xxxx x profylaxi tromboembolických xxxxxxxxxx, xxxxxxxxxxxxxxxx xxxxxxxx, xxxxx xxxx určené xxxxxxxxx k xxxxxxxxx XXX, parent. | X01XX04 xxxxxxxxxx, X01XX05 enoxaparin, X01XX06 nadroparin, X01XX08 xxxxxxxxx, B01AB12 bemiparin |
12/2 | xxxxxx k xxxxxxx xxxx k xxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxxxx, xxxxxxxxxxxxxxxx xxxxxxxx, xxxxx xxxx xxxxxx xxxxxxxxx x xxxxxxx XXX, parent. | X01XX04 dalteparin, X01XX05 xxxxxxxxxx, X01XX06 nadroparin, X01XX08 xxxxxxxxx, X01XX12 xxxxxxxxx | ||
12/3 | xxxxxx x xxxxxxx xxxx x xxxxxxxxx tromboembolických xxxxxxxxxx, xxxxx xxxxxxxxxx xxxxxxx Xx x xxxxxxxx, xxxxxx. | B01AE01 xxxxxxxxx, X01XX02 xxxxxxxxx, X01XX06 xxxxxxxxxxx | ||
13 | Léčiva x terapii xxxx x xxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxxxx | 13/1 | xxxxxx x xxxxxxx nebo x xxxxxxxxx tromboembolických xxxxxxxxxx, xxxxxxxxxxx xxxxx XXX xx xxxxxxxx, x.x. | B01AC04 xxxxxxxxxxx, X01XX05 xxxxxxxxxx, |
13/2 | léčiva x terapii xxxx x xxxxxxxxx tromboembolických xxxxxxxxxx, přímé xxxxxxxxxx xxxxxxx Xx x xxxxxxxx, x.x. | X01XX07 xxxxxxxxxx, X01X rivaroxaban, X01X xxxxxxxx | ||
14 | Xxxxxxxxxx xxxxxx k xxxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxx (XXX) | 14/1 | xxxxxxxxxx xxxxxx x xxxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxx (XXX), xxxxxx. x inhal. aplikace | X01XX09 xxxxxxxxxxxx, X01XX11 xxxxxxxx, B01AC21 xxxxxxxxxxxx |
14/2 | xxxxxxxxxx xxxxxx x xxxxxxx plicní xxxxxxxxxx xxxxxxxxxx (PAH), p.o. | X02XX01 bosentan, X02XX02 xxxxxxxxxxx, X02XX03 xxxxxxxxxx, X02X xxxxxxxxxx | ||
15 | Xxxxxxxxxxxxx, parent. | 15/1 | xxxxxxxxxxxxx, xxxxxx, parent. | X01XX02 xxxxxxxxx, X01XX04 xxxxxxxxx, X01XX11 tenektepláza |
16 | Xxxxxxxxxxxxxxxxx - xxxxxxxxxxxxx | 16/1 | antifibrinolytika, xxxxxxxxxxxxx, x.x. | B02AA02 xxxxxxxx xxxxxxxxxxx, B02AA03 xxxxxxxx aminomethylbenzoová |
16/2 | antifibrinolytika, xxxxxxxxxxxxx, xxxxxx. | B02AA02 xxxxxxxx xxxxxxxxxxx, X02XX03 xxxxxxxx aminomethylbenzoová | ||
17 | Xxxxxx k xxxxxxx xxxxxx - soli xxxxxx | 17/1 | léčiva x terapii xxxxxx, xxxxxxxxx xxxx trojmocné xxxxxx, x.x. | X03XX02 xxxxxxx xxxxxxxxx, X03XX07 xxxxx železnatý, X03XX02 xxxxxxx železa x xxxxxxxxxxx |
17/2 | léčiva x xxxxxxx anémií, trojmocné xxxxxx, xxxxxx. | X03XX02 xxxxxxx xxxxxx x xxxxxxxxxxx, X03XX07 glukonan xxxxx-xxxxxxxx | ||
18 | Faktory xxxxxxxxxxx erytropoézu působením xx xxxxxxxx erythropoetinu | 18/1 | xxxxxxx stimulující xxxxxxxxxxx, xxxxxx. | X03XX01 xxxxxxxxxxxxx (xxxxxxx xxxx), X03XX02 darbepoetin alfa, X03XX03 xxxxxxxxxx (Metoxy-polyetylenglykol- xxxxxxx xxxx), xxxxxxx xxxx, epoetin xxxxx, xxxxxxx xxxx |
20 | Xxxxxxxx NO x xxxxxxx angíny xxxxxxxx | 20/1 | donátory XX x xxxxxxx xxxxxx xxxxxxxx - terapie xxxxxxxx xxxxxxxx, subling. | X01XX02 xxxxxxxx trinitrát, X01XX08 xxxxxxxxx xxxxxxxx |
20/2 | xxxxxxxx XX x xxxxxxx anginy xxxxxxxx - terapie dlouhodobá, x.x. | C01DA02 xxxxxxxx xxxxxxxxx, X01XX08 isosorbid xxxxxxxx, X01XX14 xxxxxxxxx xxxxxxxxxx, X01XX12 molsidomin | ||
20/3 | xxxxxxxx XX x xxxxxxx xxxxxx xxxxxxxx, xxxxxx. | X01XX02 xxxxxxxx xxxxxxxxx, X01XX08 isosorbid xxxxxxxx | ||
21 | Antihypertenziva | 21/1 | xxxxxxxxxxxxxx xxxxx xxxxxxxx xxxxxxxxx x xxxxxxxxx, p.o. (xxxxx xxxxxxxxx) | C02AB01 xxxxxxxxxx, X02XX05 xxxxxxxxx, X02XX06 xxxxxxxxxx, C02CA06 urapidil |
22 | Xxxxxxxxx | 22/1 | xxxxxxxxx, x.x. | X03XX03 xxxxxxxxxxxxxxxxxx, X03XX04 chlortalidon, X03XX11 xxxxxxxxx, X03XX xxxxxxxxx |
23 | Antihypertenziva - xxxx-xxxxxxxxx | 23/1 | xxxxxxxxxxxxxxxx, xxxxxxxxxxxxx kardioselektivní xxxxxxxxxxxxx x xxxxxxxxxx xxxxxxxx, x.x. | X07XX17 xxxxxxxxxx, X07XX02 xxxxxxxxxx (xxxxxxxxxxxxx lékové xxxxx), X07XX03 atenolol, |
23/2 | antihypertenziva, xxxxxxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxx x xxxxxxxxxx xxxxxxxx, x.x. | X07XX02 xxxxxxxxxx (xxxxxxxxxxx lékové formy), X07XX04 xxxxxxxx, X07XX05 xxxxxxxxx, X07XX07 xxxxxxxxxx, X07XX08 celiprolol, X07XX12 xxxxxxxxx, C07AG02 xxxxxxxxxx | ||
24 | Xxxxxxxxxxxxxxxx - xxxxxxxxx xxxxxxxxxx xxxxxx | 24/1 | xxxxxxxxxxxxxxxx, blokátory xxxxxxxxxx kanálů dihydropyridinového xxxx xxxxxxxxxx xxxxxxxx, x.x. | X08XX01 amlodipin, X08XX02 xxxxxxxxx (xxxxxxxxxxx xxxxxx xxxxx), C08CA03 xxxxxxxxx (xxxxxxxxxxx xxxxxx xxxxx), X08XX08 xxxxxxxxxxx, X08XX09 xxxxxxxxx, X08XX10 xxxxxxxxxx, X08XX12 barnidipin, X08XX13 lercanidipin |
24/2 | xxxxxxxxxxxxxxxx, xxxxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxxxxxxxxxxxx xxxx krátkodobě x střednědobé xxxxxxxx, x.x. | X08XX02 xxxxxxxxx (xxxxxxxxxxxxx xxxxxx xxxxx), X08XX03 xxxxxxxxx (xxxxxxxxxxxxx xxxxxx xxxxx), C08CA05 xxxxxxxxx (všechny xxxxxx xxxxx) | ||
24/3 | xxxxxxxxxxxxxxxx, xxxxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxxxxxxxxxxxx x xxxxxxxxxxxxxxxxxxx xxxx, x.x. | X08XX01 xxxxxxxxx, X08XX01 xxxxxxxxx | ||
25 | Xxxxxxxxxxxxxxxx - xxxxxx xxxxxxxx na systém xxxxx- xxxxxxxxxxx-xxxxxxxxxx | 25/1 | xxxxxxxxxxxxxxxx, xxxxxxxxxx ACE xxxxxxxxxx a xxxxxxxxxxx xxxxxxxx, x.x | X09XX01 xxxxxxxxx, X09XX02 xxxxxxxxx, X09XX06 xxxxxxxxx |
25/2 | xxxxxxxxxxxxxxxx, xxxxxxxxxx ACE xxxxxxxxxx xxxxxxxx, x.x. | C09AA03 xxxxxxxxxx, C09AA04 xxxxxxxxxxx, X09XX05 xxxxxxxx, C09AA08 xxxxxxxxxx, X09XX09 fosinopril, X09XX10 xxxxxxx april, X09XX11 spirapril, X09XX13 xxxxxxxxx, X09XX16 xxxxxxxxx | ||
25/3 | xxxxxxxxxxxxxxxx, xxxxxxxxxxx xxxxxxxxxxxx XX samotné, p.o. | X09XX01 xxxxxxxx, X09XX02 xxxxxxxxxx, X09XX03 valsartan, X09XX04 ibersartan, X09XX06 xxxxxxxxxxx, X09XX07 xxxxxxxxxxx, X09XX08 xxxxxxxxxx | ||
25/4 | antihypertenziva, xxxxxxxxxxx xxxxxxxxxxx, x.x. | X03XX01 xxxxxxxxxxxxx, X03XX04 xxxxxxxxx | ||
26 | Xxxxxxxxx xxxxxxxxxxxxxx | 26/1 | periferní xxxxxxxxxxxxxx, x.x. (xxxxx xxxxxxxxxxxxxxx xxxxxxxxxx xxxxxxxxx x xxxxxxxxx dihydroergokristinu) | X04XX02 xantinol xxxxxxxxx, X04XX03 xxxxxxxxxxxx, C04AE02 xxxxxxxxxx, X04XX21 naftidrofuryl, X04XX04 etofyllin nikotinát |
26/2 | xxxxxxxxx xxxxxxxxxxxxxx, xxxxxx. | X04XX02 xxxxxxxxx, X04XX03 xxxxxxxxxxxx, C04AD xxxxxxxx | ||
27 | Xxxxxxxxxxx | 27/1 | xxxxxxxxxxx, x.x. | X05XX01 xxxxxxxxx xxxxxxxx, X05XX04 xxxxxxxxxx, C05CA53 xxxxxxx xxxxxxxxx X05XX01 tribenosid, X05XX xxxxx |
28 | Xxxxxxxxxxxxxx | 28/1 | hypolipidemika, xxxxxxx, p.o. | C10AA01 xxxxxxxxxxx, X10XX02 lovastatin, X10XX03 xxxxxxxxxxx, C10AA04 xxxxxxxxxxx, C10AA05 xxxxxxxxxxxx, X10XX07 xxxxxxxxxxxx |
28/2 | xxxxxxxxxxxxxx, xxxxxxx, x.x. | X10XX02 xxxxxxxxxx, X10XX05 xxxxxxxxxx, X10XX08 xxxxxxxxxxx | ||
29 | Xxxxxxxxxxxx xxxxxxxxx x xxxxxxxxxxxx | 29/1 | antimykotika xxxxxxxxx x xxxxxxxxxxxx x xxxxxxx xxxxxxx, (xxxxx trolamini xxxxxxxxxxxxxxxxxxxxx x tridecanamini xxxxxxxxxxx) | X01XX01 xxxxxxxx, D01AA02 xxxxxxxx, D01AC01 klotrimazol, X01XX03 xxxxxxxx, X01XX08 xxxxxxxxxxx, D0l AC10 xxxxxxxxx, D01AC11 xxxxxxxxxx, X01XX16 flutrimazol, X01XX14 xxxxxxxxxx, X01XX15 xxxxxxxxxx, X01XX22 xxxxxxxx |
29/2 | antimykotika xxxxxxxxx x xxxxxxxxxxxx x xxxxxxx xxxxxxx, xxxxxxx | X01XX04 xxxxxxxx xxxxxxxxxxxx, X01XX xxxx xxxxxxxxxxxx x zevnímu xxxxxxx | ||
30 | Antipsoriatika xxxxxxxxx x xxxxxxxxxxxx | 30/1 | antipsoriatika xxxxxxxxx x xxxxxxxxxxxx x xxxxxxx xxxxxxx, xxxxx | X05XX xxxxx, X05XX xxxxx (odbarvený dehet) |
30/2 | xxxxxxxxxxxxxx používaná x xxxxxxxxxxxx k lokální xxxxxxx, jiná xxxxxx xxx dehty | X05XX02 xxxxxxxxxxxx, X05XX03 calcitriol, X05XX04 xxxxxxxxxx, X05XX05 xxxxxxxxx | ||
31 | Xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxx | 31/1 | antibiotika xxxxxxxxx x lokální xxxxxxx | X06XX01 kyselina xxxxxxxx, X06XX09 xxxxxxxxx |
32 | Xxxxxxxxxxxxxxx xxxxxxxxx x xxxxxxx terapii - xxxxx a xxxxxxx xxxxx | 32/1 | xxxxxxxxxxxxxxx xxxxxxxxx k xxxxxxx xxxxxxx, slabé a xxxxxxx xxxxx 1. x 2. xxxxxxxx | X07XX19 xxxxxxxxxxxx acetát (0,01%), X07XX04 xxxxxxxxxxx xxxxxxxx (0,01%), D07AA02 xxxxxxxxxxxxx acetát (1,0%), X07XX03 xxxxxxxxxxx (0,4%), X07XX09 xxxxxxxxxxxx acetonid (0,1%) |
32/2 | xxxxxxxxxxxxxxx xxxxxxxxx x lokální xxxxxxx, xxxxx a xxxxxxx xxxxx 3. x 4. xxxxxxxx | X07XX10 xxxxxxxxxxxxx (0,05%), D07AB08 xxxxxxx, X07XX02 xxxxxxxxxxxxxx xxxxxxx (0,1%) | ||
33 | Xxxxxxxxxxxxxxx xxxxxxxxx x xxxxxxx terapii xxxxx x velmi xxxxx | 33/1 | kortikosteroidy používané x xxxxxxx terapii, xxxxx a xxxxx xxxxx 1. a 2. xxxxxxxx | D07AC04 xxxxxxxxxxx xxxxxxxx (0,05%- 0,2%), D07AC03 xxxxxxxxxxxxxx (0,25%) |
33/2 | xxxxxxxxxxxxxxx používané x lokální xxxxxxx, xxxxx x xxxxx xxxxx 3. x 4. xxxxxxxx | X07XX01 xxxxxxxxxxxx xxxxxxx (0,1%), X07XX01 xxxxxxxxxxxx xxxxxxxxxxx (0,05%), X07XX17 fiutikason xxxxxxxxx (0,05%), D07AC12 Xxxxxxxxxxx xxxxxxxxx (0,05%), X07XX02 Xxxxxxxxxx (0,1%), X07XX01 xxxxxxxxxx propionát (0,05%), X07XX14 xxxxxxxxxxxxxxxxx xxxxxxxx (0,1%), X07XX13 xxxxxxxxx furoát (0,1%), X07XX18 prednikarbat | ||
34 | Xxxxxxxxxxx x dezinficiencia | 34/1 | xxxxxxxxxxx x xxxxxxxxxxxxxx - obsahující xxxxxxxxx xxxxx | X08XX xxxxxxxxxx obsahující xxxxxxxxx xxxxx |
35 | Xxxxxx xxxxxxxxx x xxxxxxx xxxxxxx xxxx xxxxxxxx | 35/1 | xxxxxx xxxxxxxxx x xxxxxxx xxxxxxx xxxx xxxxxxxx, xxxxxxxxx | X10XX01 xxxxxxxxx, D10AD03 xxxxxxxx, X10XX04 xxxxxxxxxxxx |
35/2 | xxxxxx xxxxxxxxx x xxxxxxx xxxxxxx xxxx xxxxxxxx, xxxxxxx xxxxxx | X10XX01 xxxxxxx xxxxxxx, X10XX03 kyselina xxxxxxxx | ||
35/3 | xxxxxx xxxxxxxxx x xxxxxxx xxxxxxx xxxxxxxxxxxx, xxxxxxxxxxxx látky | D10AF01 xxxxxxxxxxx, D10AF02 erythromycin | ||
36 | Xxxxxxxxxxxxxxx xxxxxxxxx x xxxxxxx terapii xxxxxxxx dennatitidy | 36/1 | xxxxxxxxxxxxxxx xxxxxxxxx k xxxxxxx xxxxxxx atopické xxxxxxxxxxx | X11XX14 xxxxxxxxxx, X11XX15 xxxxxxxxxxxxx |
37 | Xxxxxxxxxxxxx xxxxxxxxxxxx | 37/1 | xxxxxxxxxxxxx xxxxxxxxxxxx, xxx. xxxx xxx. xxxxxxxx | X01XX02 xxxxxxxxxxx, G01AF05 xxxxxxxx, X01XX12 xxxxxxxxxxxx |
38 | Xxxxxxxxxxxxx xxxxxxxxxxx | 38/1 | gynekologická xxxxxxxxxxx, xxx. nebo xxx. xxxxxxxx, (xxxxx přípravků xxxxxxxxxxxx laktobacillus) | G0IAX03 xxxxxxxxxxxxx, X01XX11 xxxxxxxxx xxx, X01XX xxxxxxxxxxxx xxxxx |
39 | Xxxxxxxxxxxxx xxxxxxxxxxx používaná x xxxxxxx xxxxxxx | 39/1 | xxxxxxxxxxxxx xxxxxxxxxxx, xxx. xxxx vag. xxxxxxxx | X01XX02 xxxxxxxxx, X01XXX0 xxxxxxxxxxx, X01XX12 xxxxxxxxxx |
40 | Prostaglandiny | 40/1 | xxxxxxxxxxxxxx, parent. | X02XX01 xxxxxxxxx, X02XX04 xxxxxxxxxx |
41 | Inhibitory prolaktinu | 41/1 | inhibitory xxxxxxxxxx, xxxxxxxxxxxx xxxxxxxx X. xxxxxxxx, x.x. | G02CB01 xxxxxxxxxxxx, G02CB0G tergurid |
41/2 | xxxxxxxxxx xxxxxxxxxx, xxxxxxxxxxxx xxxxxxxx II. xxxxxxxx, x.x. | X02XX03 kabergolin, X02XX04 xxxxxxxxxx | ||
42 | Xxxxxxxxx | 42/1 | xxxxxxxxx, x.x. | X03XX03 xxxxxxxxx, X03XX04 xxxxxxx, G03DC05 xxxxxxx |
42/2 | estrogeny, xxxxxxx xxx. xxxxxxxx | X03XX03 xxxxxxxxx, X03XX04 estriol | ||
43 | Xxxxxxxxxx | 43/1 | xxxxxxxxxx X. generace, x.x. | X03XX02 xxxxxxxxxxxxxxxxxx, X03XX02 xxxxxxxxxxxxx, G03DC03 xxxxxxxxxxx |
43/2 | progestiny II. xxxxxxxx, p.o. | G03DA04 xxxxxxxxxxx, X03XX01 xxxxxxxxxxxxx | ||
43/3 | xxxxxxxxxx, xxxxxx. | X03XX03 xxxxxxxxxxxxxxxxxx, X03XX04 progesteron (xxxxxxx xxxxxx xxxxx) | ||
44 | Xxxxxxxxxxxxx | 44/1 | xxxxxxxxxxxxx xxxxxxxx, parent. | X03XX01 xxxxxxxx xxxxxxxxxxxx, X03XX08 xxxxxxxxxxxxx xxxxxxxx xxxxxxxxxxxx |
44/2 | xxxxxxxxxxxxx xxxxxxx, xxxxxx. | G03GA02 xxxxxxxxxxxx xxxxxx, xxxxxxxxxxxx xxxxxx xxxxxx xxxxxxx, G03GA04 xxxxxxxxxxxxx, xxxxxxxxxxxxx xxxxxx xxxxxxx, X03XX05 xxxxxxxxxx xxxx, G03GA06 xxxxxxxxxx xxxx, X03XX07 lutropin xxxx | ||
45 | Xxxxxx xxxxxxxxxxxx | 45/1 | xxxxxx xxxxxxxxxxxx, neretardované formy, x.x. a xxxxxxxxx. xxxxxxxx | G04BD04 oxybutinin, X04XX06 xxxxxxxxxx, X04XX07 xxxxxxxxxx, X06XX09 xxxxxxxx xxxxxxx |
45/2 | močová xxxxxxxxxxxx, xxxxxxxxxxx xxxxx, x.x. | X04XX07 tolterodin, G04BD08 xxxxxxxxxxx, X04XX10 xxxxxxxxxxx, X04XX11 xxxxxxxxxxx | ||
46 | Xxxxxx x terapii xxxxxxx xxxxxxxxxxx prostaty | 46/1 | xxxxxx k xxxxxxx xxxxxxx hyperplazie xxxxxxxx, xxxxxxxxxxx xxxx xxxxxxxxxxxx xxxxxxxxx, x.x. | X02XX04 xxxxxxxxx, G04CA01 xxxxxxxxx, X04XX02 tamsulosin, X04XX03 xxxxxxxxx |
46/2 | xxxxxx x terapii benigní xxxxxxxxxxx xxxxxxxx, xxxxxxx, x. x. | X04XX01 xxxxxxxxxx, X04XX03 mepartricin | ||
47 | Xxxxxxxxxxx xxxxxxxxx xxxxxxx | 47/1 | antagonisté xxxxxxxxx hormonu, krátkodobě xxxxxxxx, xxxxxx. | X01XX01 xxxxxxxxxxxx, H01CB02 xxxxxxxxx |
47/2 | xxxxxxxxxxx xxxxxxxxx xxxxxxx - dlouhodobě xxxxxxxx, xxxxxx. | X01XX02 xxxxxxxxx, X01XX03 xxxxxxxxx | ||
48 | Xxxxxxxxxxx gonadotropin uvolňujícího xxxxxxx | 48/1 | xxxxxxxxxxx xxxxxxxxxxxx - uvolňujícího xxxxxxx, xxxxxx. | H01CC01 xxxxxxxxx, X010002 cetrorelix |
49 | Xxxxxxxxxxxxxxx k xxxxxxxxx xxxxxxx | 49/1 | xxxxxxxxxxxxxxx s xxxxxxxxxxxx xxxxxxxxxxxxxxxxx účinkem, x.x. | X02XX04 xxxxxxxxxxxxxxxxx, X02XX07 xxxxxxxxx, H02AB08 xxxxxxxxxxxxx |
49/2 | xxxxxxxxxxxxxxx x převažujícím xxxxxxxxxxxxxxxxx xxxxxxx, xxxxxx. - depotní | X02XX01 xxxxxxxxxxxx (depotní xxxxxx xxxxx), X02XX04 xxxxxxxxxxxxxxxxx (xxxxxxx lékové formy) | ||
50 | Xxxxxxxxxxxxxxx léčiva | 50/1 | xxxxxxxxxxxxxxx xxxxxx, x.x. | X03XX02 propylthiouracil, X03XX01 karbimazol, H03BB02 xxxxxxxxxx |
51 | Xxxxxxxxxxxx | 51 /1 | tetracykliny, x.x. | X01XX02 xxxxxxxxxx, X01XX08 xxxxxxxxxx |
52 | Xxxxxxxxxx x úzkým xxxxxxxx xxxxxx | 52/1 | xxxxxxxxxx x úzkým xxxxxxxx, x.x. | X01XX02 xxxxxxxxxxxxxxxxxxxxx, X01XX06 xxxxxxxxxxx, X01XX10 benzatbin xxxxxxxxxxxxxxxxxxxxx |
53 | Xxxxxxxxxxxxx | 53/1 | xxxxxxxxxxxxx X. xxxxxxxx, x.x. | J01DB01 cefalexin, X01XX05 cefadroxil, X01XX04 xxxxxxxx, |
53/2 | xxxxxxxxxxxxx XX. xxxxxxxx, p.o. | J01DC02 xxxxxxxxx axetil, J01DC10 xxxxxxxxx | ||
53/3 | cefalosporiny I. xxxxxxxx, parent. | X01XX03 xxxxxxxxx, X01XX04 xxxxxxxxx | ||
53/4 | xxxxxxxxxxxxx III. xxxxxxxx, xxxxxx. (kromě xxxxxxxxxxxx) | X01XX01 xxxxxxxxx, X01XX02 xxxxxxxxxx, J01DD04 xxxxxxxxxx | ||
54 | Karbapenemy | 54/1 | xxxxxxxxxxx, parent. | J01DH02 xxxxxxxxx, X01XX03 xxxxxxxxx |
55 | Xxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx x xxxxxxxxxxxxx xxxxxxxxxxx | 55/1 | makrolidy, x.x. | X01XX01 xxxxxxxxxxxx, X01XX02 xxxxxxxxxx, X01XX06 xxxxxxxxxxxxx, J01FA09 xxxxxxxxxxxxxx, X01XX10 xxxxxxxxxxxx |
55/2 | xxxxxxxxxxx, x.x. | X01XX01 klindamycin, X01XX02 xxxxxxxxxx | ||
56 | Xxxxxxxxx | 56/1 | xxxxxxxxx, x.x. (xxxxx moxifloxacinu) | X01XX01 xxxxxxxxx, X01XX02 xxxxxxxxxxxxx, X01XX03 xxxxxxxxxx, X01XX06 xxxxxxxxxxx, J01MA12 xxxxxxxxxxxx |
57 | Imidazolové xxxxxxxx | 57/1 | xxxxxxxxxxx xxxxxxxx, x.x. | X01XX01 xxxxxxxxxxxx, J01XD03 xxxxxxxx |
58 | Antimykotika x xxxxxxxxx terapii | 58/1 | xxxxxxxxxxxx k xxxxxxxxx xxxxxxx, triazolové xxxxxxxx, x.x. | X02XX03 xxxxxxxxxxx, X02XX04 xxxxxxxxxxx |
59 | Xxxxxxxxx antivirotika xxxxx xxxxxxxx vyvolaným xxxxxxxxxxx xxxxxxx | 59/1 | xxxxxxxxx xxxxxxxxxxxx x xxxxxxx xxxxxxx xxxxxxxxxx xxxxxx xxxxx xxxxxxx, x.x. | X05XX01 xxxxxxxxx, X05XX09 xxxxxxxxxxx, X05XX11 valaciklovir, X05XX15 xxxxxxxx |
60 | Xxxxxxxxxxxxxxxxx | 60/1 | xxxxxxxxxxxxxxxxx xxxxxxxxxxxx x nukleotidové xxxxxxxxxx reverzní trankriptázy, xxxxx xxx HIV xxxxxxx, x.x. | X05XX02 xxxxxxxxx, J05AF04 stavudin, X05XX06 xxxxxxxx, J05AF09 xxxxxxxxxxxx |
60/2 | xxxxxxxxxxxxxxxxx nukleosidové x xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx trankriptázy, xxxxx xxx XXX xxxxxxx, x.x. | J05AF08 xxxxxxxx, X05XX10 xxxxxxxxx | ||
61 | Xxxxxxxxxx neuraininidázy | 61/1 | xxxxxxxxxx neuraminidázy, x. x. a xxxxx. xxxxxxxx | X05XX01 xxxxxxxxx, X05XX02 xxxxxxxxxxx |
62 | Xxxxxxxxxxxxxx xxxxxxxx xxxxxx | 62/1 | Imunoglobuliny normální xxxxxx, i.m. | X06XX01 xxxxxxxxxxxxxx xxxxxxxx xxxxxx xxx xxxxxxxxxxxxxxx aplikaci |
62/2 | xxxxxxxxxxxxxx xxxxxxxx xxxxxx, x.x. | X06XX01 xxxxxxxxxxxxxx xxxxxxxx lidské pro xxxxxxxxxx xxxxxxxx | ||
62/3 | Xxxxxxxxxxxxxx xxxxxxxx xxxxxx, xx. | X06XX02 imunoglobuliny xxxxxxxx xxxxxx pro xxxxxxxxxxxx xxxxxxxx | ||
63 | Xxxxxx | 63/1 | xxxxxx, xxxxxx. | X01XX01 xxxxxxxxxx, X01XX02 xxxxxxxxx |
64 | Xxxxxxxxxx xxxxxxxxxxxxx | 64/1 | xxxxxxxxxx xxxxxxxxxxxxx, x.x. | L01XE04 xxxxxxxxx, X01XX05 xxxxxxxxx |
65 | Xxxxxxxxxxxx xxxxxxx xxxxxxxxxxxx-xxxxxxxxx xxxxxxx | 65/1 | xxxxxxxxxxxx analoga gonadotropin-releasing xxxxxxx, parent. | X02XX02 xxxxxxxxxxx, X02XX03 xxxxxxxxx, X02XX04 triptorelin |
66 | Xxxxxxxxxxxxx a xxxxxxxxxx xxxxxxxx | 66/1 | antiestrogeny, x.x. | X02XX01 xxxxxxxxx, X02XX02 xxxxxxxxx |
66/2 | xxxxxxxxxx xxxxxxxx, p.o. | L02BG03 xxxxxxxxxx, L02BG04 xxxxxxxx, X02XX06 xxxxxxxxx | ||
67 | Xxxxxxxxxxxxx | 67/1 | antiandrogeny, x.x. | L02BB01 flutamid, X02XX03 xxxxxxxxxxx |
69 | Xxxxxxxxxxx a jiná xxxxxx | 69/1 | xxxxxxxxxxx xxxx xxxxxx x xxxxxxx xxxxxxxxx onkologických xxxxxxxxxx, - xxxxxxxxxxxx xxxxx, xxxxxx. | X03XX01 xxxxxxxxxx alfa natural, X03XX04 xxxxxxxxxx alfa-2a, X03XX05 interferon alfa-2b |
69/2 | xxxxxxxxxxx xxxx-2 - xxxxxxxxxx xxxxx, xxxxxx. | X03XX11 xxxxxxxxxxxxx xxxx-2x, X03XX10 xxxxxxxxxxxxx xxxx-2x | ||
69/3 | xxxxxxxxxxx x xxxxxxx xxxxxx k xxxxxxx xxxxxxxxxxx xxxxxxxx, parent. | X03XX07 xxxxxxxxxx beta-1a, X03XX08 xxxxxxxxxx beta-1b, X03XX13 xxxxxxxxxx acetat, | ||
70 | Xxxxxxxxxxxxxx | 70/1 | xxxxxxxxxxxxxx- specifická, p.o. x xxxxxx. (xxxxx xxxxxxxxxxx x xxxxxxxxxxxx) | X04XX02 xxxxxxxxxx, X04XX06 xxxxxxxx xxxxxxxxxxxxx, X04XX10 xxxxxxxxx, X04XX18 everolimus |
70/2 | xxxxxxxxxxxxxx - biologická, xxxxxx x xxxxxxx xxxxxxxxxxxx, kožních xxxx xxxxxxxxx onemocnění, xxxxxx. | X04XX01 etanercept, X04XX02 xxxxxxxxxx, X04XX04 adalimumab, X04XX21 xxxxxxxxxxx, X04XX24 xxxxxxxxx | ||
71 | Nesteroidní xxxxxxxxxxxxxx xxxxxx | 71/1 | xxxxxxxxxxx xxxxxxxxxxxxxx xxxxxx - xxxxxxxxxxxx, x.x. | X01XX05 diklofenak, X01XX01 xxxxxxxxx, X01XX05 xxxxxxxxxx, X01XX06 xxxxxxxxx, X01XX01 xxxxxxxxx, M01AE02 naproxen, X01XX03 xxxxxxxxxx, X01XX11 xxxxxxxx xxxxxxxxxxxx, X01XX12 xxxxxxxxx, X01XX17 xxxxxxxxxxxxx, X01XX02 xxxxxxxx tolfenamová, X01XX01 xxxxxxxxx, X01XX17 xxxxxxxxx |
71/2 | nesteroidní xxxxxxxxxxxxxx, xxxx. xxxxxxxx | X01XX01 xxxxxxxxxxx, M01AB05 xxxxxxxxxx, X01XX06 xxxxxxxxx, M01AE01 xxxxxxxxx, M01AE03 xxxxxxxxxx | ||
71/3 | xxxxxxxxxxx xxxxxxxxxxxxxx, xxxxxx. | X01XX05 xxxxxxxxxx, X01XX01 xxxxxxxxx, M01AC06 xxxxxxxxx, X01XX03 xxxxxxxxxx, X01XX04 xxxxxxxxx | ||
71/4 | nesteroidní protizánětlivá xxxxxx XXX 2 xxxxxxxxxx (xxxxxx), p.o. | X01XX01 celekoxib, M01AH03 xxxxxxxxxx, X01XX05 xxxxxxxxxx | ||
73 | Xxxxxxxxx působící xxxxxxxxxxxxx | 73/1 | centrálně xxxxxxxx xxxxxxxxxxxxx, p.o. | X03XX01 xxxxxxxx, X03XX02 xxxxxxxxx, X03XX04 tolperison, X03XX05 xxxxxxxxxxxxxxx, X03XX07 xxxxxxxxxx, X05XX01 xxxxxxxxxxx |
73/2 | xxxxxxxxx působící myorelaxancia, xxxxxx. | X03XX04 xxxxxxxxxx, X03XX05 xxxxxxxxxxxxxxx | ||
74 | Xxxxxx k xxxxxxx x profylaxi xxxxxxxxxxx | 74/1 | xxxxxx x xxxxxxx x xxxxxxxxx xxxxxxxxxxx, xxxxxxx X, x.x. | X11XX01 xxxxxxxxxxxxxx, X11XX05 xxxxxxxxxxxxxxx |
74/2 | léčiva x xxxxxxx x xxxxxxxxx xxxxxxxxxxx, metabolity xxxxxxxx D, p.o. | X11XX03 xxxxxxxxxxxx, X11XX04 xxxxxxxxxx | ||
74/3 | léčiva x xxxxxxx x profylaxi xxxxxxxxxxx, xxxxxxxxxxxx, x. x. | M05BA04 xxxxxxxx xxxxxxxxxxx, X05XX061xxxxxxxx xxxxxxxxxxx, X05XX07 xxxxxxxx risedronová, | ||
74/4 | xxxxxx x terapii x xxxxxxxxx xxxxxxxxxxx, xxxxxxx xxxxxxxxxxx tělísek x analoga, xxxxxx. | X05XX02 xxxxxxxxxxx, X05XX03 xxxxxxxxxxx | ||
75 | Xxxxxx x terapii xxxxxxxxxxxxx x/xxxx xxxxxxxxx u xxxxxxxxx onemocnění | 75/1 | xxxxxx x xxxxxxx xxxxxxxxxxxxx x/xxxx osteolýzy x maligních xxxxxxxxxx, xxxxxx. | M05BA02 kyselina xxxxxxxxxx, X05XX03 kyselina xxxxxxxxxxx, X05XX06 xxxxxxxx xxxxxxxxxxx, M05BA08 xxxxxxxx xxxxxxxxxxx |
76 | Xxxxxxxxxx xxxxxxx | 76/1 | anestetika xxxxxxx, parent. | X01XX01 xxxxxxxx, X01XX02 xxxxxxxxxx, X01XX03 xxxxxxxxxx, X01XX06 xxxxxxxxxxxx |
77 | Xxxxxxxxxx xxxxxxx | 77/1 | xxxxxxxxxx xxxxxxx, xxxxxx. | N01AB02 xxxxxxx, N01BB01 xxxxxxxxxx, X01XX03 xxxxxxxxxx, X01XX09 xxxxxxxxxx, N01BB10 xxxxxxxxxxxxxx, X01XX trirnekain |
78 | Xxxxxxx | 78/1 | xxxxx xxxxxxx, x.x. | X02XX03 xxxxxxxxxxx, X02XX05 oxykodon |
78/2 | xxxxx xxxxxxx, xxxxxxxxx. xxxxxxxx | N02AB03 fentanyl, X02XX01 xxxxxxxxxxx | ||
78/3 | xxxxx xxxxxxx, p.o. | X02XX08 xxxxxxxxxxxxx, X02XX02 tramadol | ||
79 | Analgetika-antipyretika | 79/1 | xxxxxxxxxx-xxxxxxxxxxxx, p.o. | X02XX01 xxxxxxxx acerylsalicylová, X02XX02 xxxxxxxxx, X02XX02 xxxxxxxxxx, X02XX01 paracetarnol |
79/2 | xxxxxxxxxx-xxxxxxxxxxxx, xxxxxx. | X02XX02 xxxxxxxxx X02XX01 xxxxxxxxxxxx | ||
80 | Xxxxxxxxxxxxx k xxxxxxx xxxxxxxx xxxxxxxx | 80/1 | xxxxxxxxxxxxx k xxxxxxx xxxxxxxx záchvatu, xxxxxxxxxx xxxxxxxx xxxxxxxxxx, x.x. | X02XX01 xxxxxxxxxxx, X02XX02 xxxxxxxxxxx, X02XX03 xxxxxxxxxxxx, X02XX06 eletriptan, X02XX07 xxxxxxxxxxxx |
80/2 | xxxxxxxxxxxxx x xxxxxxx xxxxxxxx xxxxxxxx, xxxxxxxxxx agonisté xxxxxxxxxx, xxxxx. aplikace | X02XX01 xxxxxxxxxxx, X02XX03 xxxxxxxxxxxx | ||
81 | Antiepileptika jiná | 81/1 | antiepileptika xxxx, x.x. | X03XX12 xxxxxxxxxx, X03XX16 xxxxxxxxxx |
82 | Xxxxxxxxxxxxxxxx | 82/1 | xxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxx, x.x. | N04AA02 xxxxxxxxx, X04XX04 xxxxxxxxxxx, X04XX01 xxxxxxxxxxx |
82/2 | antiparkinsonika, xxxxxxxx xxxxxxxxx, x.x. | X04XX04 ropinirol, N04BC05 xxxxxxxxxxx | ||
82/3 | antiparkinsonika, inhibitory XXXX, x.x. | X04XX01 xxxxxxxx, X04XX02 entakapon | ||
82/4 | xxxxxxxxxxxxxxxx, inhibitory XXX, x. x. | N04BD01 xxxxxxxxx, X04XX02 rasagilin | ||
83 | Xxxxxxxxxxxxxx xxxxxxxxxxxx | 83/1 | xxxxxxxxxxxxxx, neuroleptika xxxxxxxx - I. xxxxx, x. o. | X05XX01 xxxxxxxxxxxxx X05XX03 xxxxxxxxxxxxxx, X05XX05 xxxxxxxxxxxxx |
83/2 | xxxxxxxxxxxxxx, - xxxxxxxxxxxx xxxxxxxx XX. třídy, x.x. | N05AD01 xxxxxxxxxxx, X05XX01 xxxxxxxxxxx | ||
83/3 | xxxxxxxxxxxxxx, xxxxxxxxxxxx, parent. - xxxxxxxxx | N05AA01 xxxxxxxxxxxxx, X05XX02 levomepromazin, X05XX01 xxxxxxxxxxx, X05XX05 xxxxxxxxxxxxx | ||
83/4 | xxxxxxxxxxxxxx, xxxxxxxxxxxx - X. třídy, xxxxxx. - xxxxxxx | X05XX02 xxxxxxxxxx, X05XX xxxxxxxxxxxx | ||
83/5 | xxxxxxxxxxxxxx, neuroleptika - xX. xxxxx, xxxxxx. - xxxxxxx | X05XX01 xxxxxxxxxxx, N05AF01 xxxxxxxxxxx, X05XX05 xxxxxxxxxxxxx | ||
83/6 | xxxxxxxxxxxxxx x xxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxx, x.x. | X05XX03 xxxxxxxx, X05XX03 tiaprid | ||
84 | Antipsychotika - XX. xxxxxxxx | 84/1 | xxxxxxxxxxxxxx druhé volby xxx xxxxxxx xxxxxxxxxxx, x.x. | X05XX03 xxxxxxxxx, X05XX04 quetiapin, X05XX05 xxxxxxxxxx, X05XX11 xxxxxxx |
84/2 | xxxxxxxxxxxxxx třetí volby - speciální, x.x. | X05XX04 xxxxxxxxxx, X05XX03 xxxxxxxxx, X05XX12 xxxxxxxxxxx | ||
84/3 | xxxxxxxxxxxxxx speciální, xxxxxx. - nedepotní | N05AE04 xxxxxxxxxx, N05AH03 xxxxxxxxx | ||
85 | Xxxxxxxxxxx | 85/1 | xxxxxxxxxxx, xxxxxxxxxxxxxx, x.x. | X05XX01 xxxxxxxx, N05BA02 xxxxxxxxxxxxxxx, X05XX03 xxxxxxxxx, X05XX04 xxxxxxxx, N05BA08 xxxxxxxxxx, N05BA09 xxxxxxxx, X05XX12 alprazolam, X05XX23 xxxxxxxxx |
86 | Xxxxxxxxxxxxx | 86/x | xxxxxxxxxxxxx, neselektivně xxxxxxxx xxxxxxxxxx reuptake xxxxxxxxx, x.x. | N06AA02 xxxxxxxxx, N06AA04 klomipramin, X06XX08 xxxxxxxxxx, X06XX10 xxxxxxxxxxxx, X06XX16 dosulepin, X06XX21 xxxxxxxxxx, X06XX03 xxxxxxxxx |
86/2 | antidepresiva, selektivní xxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxx xxxxxxxxxxxxx xxxxxx (SSRI, XXXX, XXXX); reverzibilní inhibitory xxxxxxxxxxxxxxxx (XXXX); enhancery xxxxxxxx xxxxxxxxxx (XXX), x. x. | N06AB03 xxxxxxxxx, X06XX04 xxxxxxxxxx, X06XX05 xxxxxxxxx, X06XX06 xxxxxxxxx, N06AB08 xxxxxxxxxx, X06XX10 xxxxxxxxxxxx, X06XX05 xxxxxxxx, X06XX14 xxxxxxxxx | ||
86/3 | xxxxxxxxxxxxx, xxxxxxxxxx xxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx xx dva transmiterové xxxxxxx (XXXX, XxXXX, XXXX), p.o. | X06XX11 xxxxxxxxxx, X06XX16 xxxxxxxxxx, X06XX17 xxxxxxxxxxx, X06XX xxxxxxxxx | ||
87 | Léčiva x terapii xxxxxxx Xxxxxxxxxxxx xxxx | 87/1 | xxxxxx x xxxxxxx Xxxxxxxxxxxx xxxxxxx, p.o. x xxxxxxxxx. aplikace | X06XX02 xxxxxxxxx, X06XX03 xxxxxxxxxxx, X06XX04 galantamin, X06XX01 memantin |
88 | Xxxxxxxxxx | 88/1 | xxxxxxxxxx, x.x. | X06XX02 pyritinol, X06XX03 xxxxxxxxxx, N06BX18 xxxxxxxxxx, X06XX02 extrakty x Xxxxxx biloba |
88/2 | xxxxxxxxxx, xxxxxx. | X06XX03 xxxxxxxxx, X06XX18 xxxxxxxxxx | ||
89 | Xxxxxxxxxxxxxxxxxxx | 89/1 | xxxxxxxxxxxxxxxxxxx, x.x. (xxxxx xxxxxxxxxx) | N07AA01 neostigmin, X07XX02 pyridostigmin, X07XX30 xxxxxxxxxx |
90 | Léčiva xxxxxxxxx k xxxxxxx xxxxxxx x x xxxxxxxxx alergické xxxxxxxxx | 90/1 | xxxxxx xxxxxxxxx x xxxxxxx xxxxxxx x k xxxxxxxxx xxxxxxxxx xxxxxxxxx, kortikosteroidy, xxxxxxxxxx. xxxxxxxx | X01XX01 xxxxxxxxxxxx, R01AD05 xxxxxxxxx, X01XX06 xxxxxxxxx, X01XX08 xxxxxxxxxx |
90/2 | léčiva xxxxxxxxx x xxxxxxx xxxxxxx x k xxxxxxxxx xxxxxxxxx xxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxxx. aplikace | R01AC02 xxxxxxxxxxxx, X01XX03 xxxxxxxxx | ||
91 | Léčiva xxxxxxxxx x xxxxxxx xxxxxxx xxxxxxx | 91/1 | léčiva Xxxxxx používaná x xxxxxxx terapii xxxxxxx, x.x. | X03XX02 xxxxxxxxxx, X03XX08 xxxxxxxxxx, X03XX13 xxxxxxxxxxx |
91/2 | xxxxxx Xxxxxx xxxxxxxxx x xxxxxxx xxxxxxx xxxxxxx, xxxxx. xxxxxxxx | R03AC02 xxxxxxxxxx, X03XX03 xxxxxxxxxx, X03XX04 xxxxxxxxx x xxxx xxxxxxxxxxxxx | ||
92 | Xxxxxxxxxxx xxxxxxxxxxxxx - xxxxxxxxxxxxxxx | 92/1 | xxxxxxxxxxx antiastmatika, xxxxxxxxxxxxxxx, - xx xxxxx xxxxxxxx, suspense x xxxxxxx, xxxxx. xxxxxxxx | X03XX02 budesonid, X03XX05 xxxxxxxxxx, X03XX08 xxxxxxxxxx |
92/2 | xxxxxxxxxxx xxxxxxxxxxxxx, xxxxxxxxxxxxxxx - xxxxxx, xxxxx xxxxxxxx | X03XX02 xxxxxxxxx, X03XX05 xxxxxxxxxx | ||
93 | Preventivní antiastmatika | 93/1 | xxxxxxxxxxx antiastmatika xx xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxx, inhal. xxxxxxxx | X03XX12 xxxxxxxxxx, X03XX13 formoterol |
93/2 | xxxxxxxxxxx xxxxxxxxxxxxx, xxxxxxx, p.o. | X03XX04 xxxxxxxx (xxxxxxxxxxx xxxxxx xxxxx), X03XX05 xxxxxxxxxx (xxxxxxxxxxx xxxxxx xxxxx) | ||
93/3 | xxxxxxxxxxx antiastmatika, xxxxxxxxxxxxxxxx, x. x. | X03XX01 xxxxxxxxxxx, X03XX03 xxxxxxxxxxx | ||
93/4 | xxxxxxxxxxx xxxxxxxxxxxxx, xxxxxxxxxxxxxxxx x xxxxxxxxxxxx, xxxxx. xxxxxxxx | R03BB01 xxxxxx xxxxxxxxxx, X03XX04 xxxxxx tiotropia | ||
93/5 | preventivní xxxxxxxxxxxxx, xxxxx kombinace, xxxxx. aplikace | X03XX12 xxxxxxxxxx/ R03BA05 xxxxxxxxxx, X03XX13 xxxxxxxxxx/ X03XX02 xxxxxxxxx, X03XX13 xxxxxxxxxx/ X03XX01 xxxxxxxxxxxxx | ||
94 | Xxxxxxxxxxxxx | 94/1 | expektorancia, x.x. | X05XX01 xxxxxxxxxxxxx, X05XX02 xxxxxxxxx, X05XX06 xxxxxxxx, X05XX15 xxxxxxxxx |
94/2 | xxxxxxxxxxxxx, parent. x xxxxx. aplikace | X05XX01 xxxxxxxxxxxxx, X05XX02 xxxxxxxxx, X05XX03 xxxxxxxxxxxx, X05XX05 xxxxx, X05XX06 xxxxxxxx | ||
95 | Xxxxxxxxxx | 95/1 | xxxxxxxxxx, x. o. (xxxxx xxxxxxx) | X05XX01 xxxxxxxxxxx, X05XX09 dextromethorfan, X05XX13 xxxxxxxxx, R05DB19 xxxxxxxxxxx, R05DB27 levodropropizin |
96 | Antihistaminika | 96/1 | xxxxxxxxxxxxxxx xxxxxxxxx, x.x. | X06XX04 xxxxxxxxx, X06XX03 xxxxxxxxxx, X06XX02 promethazin, X06XX xxxxxxxxx, X06XX02 xxxxxxxxxxxxx, X06XX17 ketotifen |
96/2 | xxxxxxxxxxxxxxx nesedativní, x.x. | X06XX07 xxxxxxxxx, X06XX09 xxxxxxxxxxxxx, X06XX13 loratadin, X06XX27 xxxxxxxxxxxx | ||
97 | Xxxxxxxxxxxxx - xxxxxxxxxxxxx | 97/1 | oftalmologika, xxxxxxxxxxxxxxx, xxxxxxxxx, lok. | S01AX11 xxxxxxxxx, X01XX13 xxxxxxxxxxxxx, X01XX17 lomefloxacin, X01XX19 xxxxxxxxxxxx |
97/2 | xxxxxxxxxxxxx, antiinfektiva, xxxxxxxxxxx xxxxxxx, xxx. | X01XX01 chloramfenikol, X01XX11 xxxxxxxxxx, X01XX12 xxxxxxxxxx, X01XX13 xxxxxxx xxxxxxxxx, X01XX24 xxxxxxxxx, X01XX04 xxxxxxxxxxxx | ||
97/3 | xxxxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxxx, lok. | X01XX03 xxxxxxxxx, S01AD09 ganciklovir | ||
98 | Xxxxxxxxxxxxx - xxxxxxxxxxxxxxx | 98/1 | xxxxxxxxxxxxx, xxxxxxxxxxxxxxx xxxx řady, xxx. | X01XX01 xxxxxxxxxxxx, X01XX02 xxxxxxxxxxxxx |
98/2 | xxxxxxxxxxxxx, xxxxxxxxxxxxxxx xxxxx xxxx, xxx. | X01XX03 xxxxxxxx, X01XX04 xxxxxxxxxxx, X01XX07 xxxxxxxxxxxxxx | ||
99 | Xxxxxxxxxxxxx - xxxxxxxxxxxxxx léčiva | 99/1 | xxxxxxxxxxxxx, xxxxxxxxxxxxxx xxxxxx, lok. | X01XX01 xxxxxxxxxxx, X01XX03 xxxxxxxxxx |
100 | Xxxxxxxxxxxxx používaná x xxxxxxx xxxxxxxx | 100/1 | xxxxxxxxxxxxx používaná x xxxxxxx xxxxxxxx, xxxxxxxxxxxxxxx xxxx xxxxxxxxxxxxxxxxxxx, xxx. | S01EA04 xxxxxxxx, X01XX05 xxxxxxxxxx, S01EB01 xxxxxxxxxx |
100/2 | xxxxxxxxxxxxx xxxxxxxxx x terapii xxxxxxxx, xxxxxxxxxx karboanhydrázy, lok. | X01XX03 dorzolamid, X01XX04 xxxxxxxxxxx | ||
100/3 | xxxxxxxxxxxxx používaná x xxxxxxx xxxxxxxx, xxxxxxxxxxxxx, lok. | X01XX01 xxxxxxx, S01ED02 xxxxxxxxx, X01XX03 xxxxxxxxxxx, X01XX05 xxxxxxxxx | ||
100/4 | xxxxxxxxxxxxx xxxxxxxxx x terapii xxxxxxxx, xxxxxxxxxxxxxx xxxx xxxxxx xxxxxxxx, xxx. | X01XX01 xxxxxxxxxxx, S01EE02 imoproston, X01XX03 xxxxxxxxxxx, S01EE04 xxxxxxxxxx | ||
101 | Oftalmologika - xxxxxxxxxx a xxxxxxxxxxxx | 101/1 | xxxxxxxxxxxxx, xxxxxxxxxx a xxxxxxxxxxxx, xxx. | X01XX01 xxxxxxx, X01XX04 cyklopentolát, X01XX06 xxxxxxxxxx, X01XX01 xxxxxxxxxx (xxxxxxxxxxx 10 % xxxx xxxx) |
102 | Xxxxxxxxxxxxx - antialergika (xxxxx kortikosteroidů) | 102/1 | xxxxxxxxxxxxx, xxxxxxxxxxxx - xxxxxxxxxxxxxxx, lok. | S01GA52 xxxxxxxxxx xxxxxxxxxx, S01GX02 xxxxxxxxxxxx, S01GX06 xxxxxxxxx, X01XX07 xxxxxxxxx, X01XX10 xxxxxxxxx |
102/2 | xxxxxxxxxxxxx, xxxxxxxxxxxx - xxxxxxxxxxxxx xxxxxxx xxxxx, xxx. | S01GX01 xxxxxxxx kromoglyková, S01GX03 xxxxxxxx xxxxxxxxxx, X01XX05 xxxxxxxxx, X01XX08 xxxxxxxxx, X01XX09 xxxxxxxxxx | ||
103 | Xxxxxx používaná x xxxxxxx věkem podmíněné xxxxxxxxx xxxxxxxxxx | 103/1 | xxxxxx k terapii xxxxx xxxxxxxxx xxxxxxxxx xxxxxxxxxx, xxx. | X01XX01 xxxxxxxxxxx, S01LA03 xxxxxxxxxx, X01XX04 xxxxxxxxxxx |
104 | Xxxxxxxxxxxx xxxxxxxx alergenů | 104/1 | terapeutické xxxxxxxx xxxxxxxx - xxxxxxxxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxx | V01AA xxxxxxxx xxxxxxxx |
104/2 | xxxxxxxxxxxx xxxxxxxx xxxxxxxx - xxxxxxxxxxxxxxx neinjekční, xxxxxxxxx | X01XX xxxxxxxx xxxxxxxx | ||
104/3 | xxxxxxxxxxxx xxxxxxxx xxxxxxxx - standardizované xxxxxxxxxx, xxxxxxxxxxxx | V01AA xxxxxxxx xxxxxxxx | ||
104/4 | xxxxxxxxxxxx xxxxxxxx xxxxxxxx - nestandardizované, xxxxxxxx vodné | X01XX xxxxxxxx xxxxxxxx | ||
104/5 | xxxxxxxxxxxx xxxxxxxx xxxxxxxx - xxxxxxxxxxxxxxxxx, xxxxxxxx depotní | X01XX xxxxxxxx alergenů | ||
104/6 | xxxxxxxxxxxx xxxxxxxx xxxxxxxx - xxxxxxxxxxxxxxx xxxxxxxx xxxxx | V01AA xxxxxxxx xxxxxxxx | ||
104/7 | xxxxxxxxxxxx xxxxxxxx xxxxxxxx - standardizované, xxxxxxxx depotní | X01XX xxxxxxxx xxxxxxxx | ||
105 | Xxxxx xxx alergické xxxxxxx | 105/1 | xxxxx xxx xxxxxxxxx choroby - intradennální | V04CL xxxxx xxx alergické xxxxxxx |
105/2 | xxxxx xxx xxxxxxxxx choroby - xxxxx xxxxx | X04XX xxxxx xxx alergické xxxxxxx | ||
106 | Xxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxxx x hyperfosfatemie | 106/1 | xxxxxx x xxxxxxx xxxxxxxxxxxx x xxxxxxxxxxxxxxx, x.x. | X03XX02 xxxxxxxxx, X03XX03 lanthankarbonát |
107 | Xxxxxx pro xxxxxxx poruchy xxxxxxxxxxx | 107/1 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx xxxxxxxxxxxx (xxxxxxxx xxxxx xx xxxxx xxxxxxxxxxxx) | V06CA01 |
107/2 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx fenylalaninu s xxxxxxx xxxxxxxxx x xxxx xxx xxxx xx 1 xxxx (xxxxxxxx xxxxx na xxxxx aminokyselin) | X06XX02 | ||
107/3 | xxxxxxxxxx směsi xxxxxxxxxxxx xxx fenylalaninu xxx xxxxxxx (xxxxxxxx formy xx obsah aminokyselin) | X06XX04 | ||
107/4 | definované xxxxx xxxxxxxxxxxx xxx xxxxxxxxxxxx (xxxxxxxxx xxxxx xx xxxxx aminokyselin) | V06CA05 | ||
107/5 | xxxxxxxxxx směsi xxxxxxxxxxxx xxx xxxxxxxxxxxx (xxxxxxxxx xxxxx tekuté xx xxxxx xxxxxxxxxxxx) | X06XX11 | ||
107/6 | xxxxxxxxxx směsi esenciálních xxxxxxxxxxxx pro xxxx xx 1 roku x poruchou metabolismu xxxxx xxxxxxxx (xxxxxxxx xxxxx xx xxxxx xxxxxxxxxxxx) | V06DD12 | ||
107/7 | xxxxxxxxxx xxxxx esenciálních aminokyselin xxx xxxxxxxx xxx 1 rok x xxxxxxxx xxxxxxxxxxx cyklu xxxxxxxx (práškové xxxxx xx xxxxx xxxxxxxxxxxx) | X06XX13 | ||
107/8 | xxxxxxxxxx směsi xxxxxxxxxxxx bez isoleucinu, xxxxxxx a valinu xx xxxxxxxxx x xxxx pro děti xx 1 xxxx - xxxxxxxxx kojenecká xxxxxx (xxxxxxxx formy xx xxxxx aminokyselin) | X06XX14 | ||
107/9 | xxxxxxxxxx směsi xxxxxxxxxxxx xxx xxxxxxxxxx, xxxxxxx x xxxxxx xxx xxxx xx 1 roku (xxxxxxxx xxxxx xx xxxxx xxxxxxxxxxxx) | V06DD14 | ||
107/10 | definované xxxxx xxxxxxxxxxxx xxx xxxxxxxxxx, xxxxxxx x xxxxxx pro pacienty xxx 1 rok (xxxxxxxx formy na xxxxx xxxxxxxxxxxx) | X06XX15 | ||
107/11 | xxxxxxxxxx směsi xxxxxxxxxxxx xxx isoleucinu, xxxxxxxxxx, xxxxxxxxx x xxxxxx xxx xxxx x xxxxxxxxxxxxxx a propionovou xxxxxxxx do 1 xxxx (xxxxxxxx xxxxx xx obsah aminokyselin) | X06XX16 | ||
107/12 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx isoleucinu, xxxxxxxxxx, xxxxxxxxx x xxxxxx xxx pacienty x xxxxxxxxxxxxxx a xxxxxxxxxxx xxxxxxxx xxx 1 rok (xxxxxxxx xxxxx xx obsah xxxxxxxxxxxx) | X06XX17 | ||
107/13 | definované xxxxx xxxxxxxxxxxx xxx xxxxxxx pro děti xx 1 roku (xxxxxxxx xxxxx xx xxxxx xxxxxxxxxxxx) | X06XX18 | ||
107/14 | xxxxxxxxxx xxxxx aminokyselin xxx xxxxxxx pro xxxxxxxx nad 1 xxx (práškové xxxxx xx xxxxx aminokyselin) | X06XX19 | ||
107/15 | definované směsi xxxxxxxxxxxx xxx xxxxxx x xx sníženým xxxxxxxxx tryptofanu pro xxxx x glutarovou xxxxxxxx xx 1 xxxx (práškové formy xx xxxxx xxxxxxxxxxxx) | X06XX20 | ||
107/16 | definované xxxxx xxxxxxxxxxxx bez xxxxxx x se xxxxxxxx xxxxxxxxx xxxxxxxxxx xxx xxxxxxxx s xxxxxxxxxx xxxxxxxx xxx 1 xxx (xxxxxxxx formy xx xxxxx xxxxxxxxxxxx) | X06XX21 | ||
107/17 | definované směsi xxxxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxx L-cystinem xxx xxxx x xxxxxxxxxxxxxx xx 1 xxxx (xxxxxxxx xxxxx na xxxxx aminokyselin) | X06XX22 | ||
107/18 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxx X-xxxxxxxx xxx pacienty x xxxxxxxxxxxxxx xxx 1 xxx (xxxxxxxx xxxxx xx xxxxx xxxxxxxxxxxx) | V06DD23 | ||
107/19 | definované xxxxx xxxxxxxxxxxx bez xxxxxxxx x xxxxxxxxxxxx xx xxxxxxxxx x xxxx pro xxxx xx 1 xxxx - kompletní xxxxxxxxx xxxxxx (xxxxxxxx xxxxx xx obsah aminokyselin) | X06XX26 | ||
107/20 | definované xxxxx xxxxxxxxxxxx bez xxxxxxxx x fenylalaninu pro xxxx xx 1 xxxx (xxxxxxxx xxxxx xx xxxxx xxxxxxxxxxxx) | X06XX26 | ||
107/21 | definované xxxxx xxxxxxxxxxxx xxx xxxxxxxx x xxxxxxxxxxxx xxx xxxxxxxx nad 1 xxx (práškové formy xx obsah aminokyselin) | X06XX27 | ||
107/22 | xxxxxxxxxx směsi xxxxxxxxxxxx xxxxxx xxxxxxxxx x xxxxxxx s xxxxxx xxxxxxx xxxxxxxxxxxx (xxxxxxxx xxxxx na xxxxx xxxxxxxxxxxx) | X06XX29 | ||
108 | Xxxxxx xxxxxxxxx xxxxxx | 108/1 | Xxxxxxxxx xxxxxx xxxxxxxxxx - x xxxxxx formě | X06XX01 |
108/2 | Xxxxxxxxx xxxxxx xxxxxxxxxx - hyperkalorická | X06XX01 | ||
108/3 | Xxxxxxxxx výživa xxxxxxxxxx - s xxxxxxxx xxxxxxxx xxxxxxxxxxxx | X06XX02, V06EB04 | ||
108/4 | Xxxxxxxxx xxxxxx xxxxxxxxxx - x doplňkem vlákniny xxxxxxxxxxxxxxx | V06EB02, X06XX04 | ||
108/5 | Xxxxxxxxx xxxxxx xxxxxxxxx - hyperkalorická xxx xxxx | X06XX03 | ||
108/6 | Xxxxxxxxx xxxxxx speciální - xxxxxxxxxxxxxx x xxxxxxxx xxxxxxxx xxxxx xxxxxxxx x xxxxxxxx | X06XX05, X06XX06 | ||
108/7 | Polymerní výživa xxxxxxxxx - xxxxxx xxx xxxxx xxxxxxxxx xxxxxxx | X06XX10 | ||
108/8 | Xxxxxxxxx xxxxxx xxxxxxxxx - x xxxxxxxx proteinu, xxxxxxxx a xxxxx | X06XX11 | ||
108/9 | Xxxxxxxxx výživa xxxxxxxxx - s xxxxxxxx imunonutrientů a xxxxxxxxxxxx | V06EB07, V06EB12, X06XX13, X06XX14, X06XX15, X0XXX16 | ||
108/10 | Polymerní xxxxxx xxxxxxxxx - xxxxxxxxxx | X06XX08 | ||
108/11 | Polymerní výživa xxxxxxxxx - s xxxxxxxx MCT xxxxx | X06XX09 | ||
108/12 | Xxxxxxxxxxxxxxx xxxxxx xxxxxx | X06XX01 | ||
108/13 | Xxxxxxxxxxxx | X06XX01 | ||
109 | Výživy - náhrady xxxxx | 109/1 | xxxxxxx mléka x xxxxxxx xxxxxxxxx xxxxxxxxx xxxxx | V06DF01 |
109/2 | xxxxxxx xxxxx x xxxxxxx proteinovým hydrolyzátem | X06XX02 | ||
109/3 | xxxxxxx xxxxx x nízkým xxxxxxx xxxxxxx a xxxxxxx xxxxxxxxxxx xxxxxxxxxxxx | X06XX04 | ||
109/4 | xxxxxxxxx kojenecká xxxxxx x obsahem xxxxxxxxxxxx xxxxxxxxxxxx | X06XX | ||
110 | XXX xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx rtg kontrastní xxxxx xxxxxxxxx | 110/1 | XXX xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx xxx-xxxxxxxxxx látky - xxxxxxxxx - xxxxxxxxxxx xxxx 150 xx/xx, xxxxxx. | X08XX09 xxxxxxxxx, X08XX10 xxxxxxxx |
110/2 | XXX xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx rtg-kontrastní látky - neionické - xxxxxxxxxxx xxxx 200 xx/xx, xxxxxx. | X08XX04 xxxxxxxxxx, V08AB10 xxxxxxxx | ||
110/3 | XXX vodorozpustné nízkoosmolární xxxxxxxxxxx xxx-xxxxxxxxxx xxxxx - xxxxxxxxx - xxxxxxxxxxx xxxx 240 xx/xx, xxxxxx. | V08AB02 xxxxxxx, X08XX05 xxxxxxxx, X08XX07 xxxxxxxx | ||
110/4 | XXX xxxxxxxxxxxxx nízkoosmolární nefrotropní xxx-xxxxxxxxxx xxxxx - xxxxxxxxx - xxxxxxxxxxx xxxx 300 xx/xx, xxxxxx. | X08XX02 iohexol, X08XX04 xxxxxxxxxx, X08XX05 xxxxxxxx, X08XX07 ioversol, X08XX10 iomeprol, X08XX11 xxxxxxxxxx | ||
110/5 | XXX xxxxxxxxxxxxx xxxxxxxxxxxxxx nefrotropní xxx-xxxxxxxxxx xxxxx - xxxxxxxxx - koncentrace xxxx 320 xx/xx, xxxxxx. | X08XX03 xxxxxxxx xxxxxxxxxxx, X08XX07 xxxxxxxx, X08XX09 xxxxxxxxx | ||
110/6 | XXX xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx rtg-kontrastní xxxxx - xxxxxxxxx - xxxxxxxxxxx xxxx 350 xx/xx, xxxxxx. | X08XX02 xxxxxxx, V08AB07 xxxxxxxx, V08AB10 xxxxxxxx, X08XX11 iobitridol | ||
110/7 | XXX xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx xxx-xxxxxxxxxx xxxxx - xxxxxxxxx - xxxxxxxxxxx xxxx 370 mg/ml, xxxxxx. | X08XX04 Xxxxxxxxx, X08XX05 iopromid | ||
111 | Xxxxxxxxxx látky xxx xxxxxxxxx ultrazvukem | 111/1 | xxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxxxxx, parent. | X08XX01 xxxxxxxxxxxx x xxxxxxxxx, X08XX05 xxxxxx xxxxxxxxxxx |
*) Xxxx-xx xxxxxxx x příslušné xxxxxxxxxx xxxxxxx xxxxx podání, xxx xx takové xxxxxxxxxx xxxxxxx xxxxxx xxxxxxx x xxxxxx xxxxxxxxxxxx zaměnitelné xxxxxx xxxxxxxxx x obdobnou xxxx xxxxxxx xxxxxxxxx x xxxxxxxxxxx x xxxxxxxx klinickým xxxxxxxx, xxx xxxxxxx xxxxxx xxxxx xxxxxx.
Čl. XX
Xxxx xxxxxxxx xxxxxx xxxxxxxxx xxxxxxxxx xxxx xxx dne jejího xxxxxxxxx.
Ministryně:
Xxxxxxxxx v. x.
Xxxxxxxxx
Xxxxxx předpis x. 114/2009 Sb. xxxxx xxxxxxxxx dnem 13.5.2009.
Xxxxx jednotlivých xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxx aktualizováno, xxxxx xx jich xxxxxx derogační xxxxx xxxxx uvedeného právního xxxxxxxx.